ALLEGRA-D 24 HOUR OTC
Generic Name and Formulations:
Fexofenadine HCl 180mg, pseudoephedrine HCl 240mg; ext-rel tabs.
Indications for ALLEGRA-D 24 HOUR:
Seasonal allergic rhinitis with nasal congestion.
Swallow whole. Take on an empty stomach. 1 tab once daily. Renal insufficiency: not recommended.
Narrow-angle glaucoma. Urinary retention. Severe hypertension or coronary artery disease. During or within 14 days of stopping MAOIs.
Hypertension. Diabetes. Ischemic heart disease. Increased intraocular pressure. Hyperthyroidism. Renal impairment. GI or GU obstruction. Seizure disorders. Elderly. Pregnancy (Cat.C). Nursing mothers: not recommended.
Antihistamine + sympathomimetic.
See Contraindications. Avoid concomitant aluminum- or magnesium-containing antacids. Pseudoephedrine: Antagonizes antihypertensives. Increased ectopic pacemaker activity with digitalis. Avoid other sympathomimetics. Fruit juices (eg, grapefruit, orange, apple) may reduce plasma levels.
Headache, insomnia, nausea, dry mouth, dyspepsia, throat irritation, dizziness, agitation, back or abdominal pain, palpitations, nervousness, anxiety, upper respiratory infection.
Tabs 24hr—100; 12hr—100, 500
Endocrinology Advisor Articles
- Cushing Syndrome Results in Poor Quality of Life Even After Remission
- DPP-4 Inhibitors and Incidence of Rheumatoid Arthritis in Type 2 Diabetes
- Cost-Benefit Analysis of Insulin Analogs in Type 2 Diabetes
- Nonfunctioning Adrenal Incidentaloma Associated With Metabolic Syndrome
- Low Predictive Power of Biomarkers for Estimated Glomerular Filtration Rate Decline
- Nutraceuticals May Benefit Patients Who Are Statin Intolerant
- Link Between Gestational Diabetes and Risk for CVD and Diabetes in Hispanic/Latina Population
- Clinical Characteristics Altering Risks and Benefits of Sulfonylureas and Thiazolidinedione Therapy in T2D
- 6 Factors Related to Inclusion in Health Care Workplace Identified
- Weight Gain After Quitting Smoking May Increase Risk for T2D